Alumna Develops Alzheimer's Drug Discovery Foundation Agenda

Nancy Lynn ’96 is making a point of not letting the world forget about Alzheimer’s. As the Alzheimer’s Drug Discovery Foundation’s executive vice president, she has significantly broadened the charity’s fundraising agenda. Since Lynn took up the post in 2009, the foundation has better equipped researchers to develop drugs to treat or cure the disease, which affects 5.5 million Americans.

By focusing on high-end donors through a host of annual events, Lynn continues to attract supporters to the foundation, including former Supreme Court Justice Sandra Day O’Connor, the foundation’s honorary chairwoman.